CSInvestor Access

Platform

One platform, built around product, quality and distribution

The current platform thesis connects product development, regulatory capability and international distribution.

Flagship product

CarciReagent®

CarciReagent® is an in vitro diagnostic medical device intended for self-testing. It uses a urine sample and a chemical chromogenic reaction for indicative semi-quantitative evaluation.

ImportantA positive result is not a diagnosis. The test provides indicative information and does not replace professional medical evaluation.
IVD self-testIntended for home use according to product documentation.
Non-invasive sampleThe test uses a urine sample.
Chromogenic principleThe result is shown through a colour reaction compared with the supplied scale.
Regulatory foundationThe manufacturer publishes relevant regulatory and quality documentation.

Simple home-use workflow

Four steps from sample to indicative result

01
SampleCollect the urine sample in line with the approved instructions.
02
ReactionUse the test system according to the instructions.
03
ReadCompare the colour reaction with the supplied scale.
04
Next stepInterpret the result only within the approved intended use.

Public information is presented in line with available source materials. Forecasts are management estimates and future results are not guaranteed.